QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: GVP Module VI Special Situations and ICSR Reporting

Test your understanding of the concepts covered by GVP Module VI: Special Situations and ICSR Reporting.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A mature special-situations process is best characterised by which combination of controls?

Automatic ICSR creation, minimal follow-up, and reliance on individual processor judgement Clear definitions, controlled intake, appropriate assessment, accurate coding, risk-based follow-up, cross-functional interfaces, metrics, and QPPV oversight Separate quality and pharmacovigilance systems with no information exchange Focus on case counts while excluding classification consistency from quality oversight

Question 2 of 10 A patient uses a medicine outside its authorised indication and develops a suspected adverse reaction. Which processing approach is best?

Treat the off-label use as proof that the medicine caused the reaction Ignore the indication because only the reaction matters Capture the indication, exposure circumstances, and reaction, while assessing causality separately Reject the information because off-label use cannot generate an ICSR

Question 3 of 10 What is the main control objective when a safety report involves a medical device or combination product?

Assign the report to the function that received it and take no further action Identify the relevant product and define which reporting framework and organisational responsibilities apply Treat the case as a medicinal-product adverse reaction regardless of the device contribution Transfer all responsibility to the device manufacturer without documenting the handoff

Question 4 of 10 Which information is particularly important when assessing a breastfeeding exposure?

Only the mother's treatment start date Only whether the medicine was prescribed within the authorised indication Maternal exposure and treatment, breastfeeding status, infant exposure where known, and any effects in the infant The infant's outcome without recording the maternal medicinal-product exposure

Question 5 of 10 When processing an intentional overdose associated with possible self-harm, which practice is most appropriate?

Record only the overdose and omit the circumstances of intentionality Infer the person's psychiatric diagnosis from the intentional act Document the known circumstances and clinical effects without adding unsupported conclusions Classify the event as medication error because the dose exceeded the intended dose

Question 6 of 10 Which organisational weakness is most likely to cause an ICSR to be delayed or missed when a medication error is reported through product quality?

Having both quality and pharmacovigilance procedures Using controlled terminology for medication errors A missing or ineffective interface for transferring associated clinical information to pharmacovigilance Conducting follow-up on the patient's outcome

Question 7 of 10 How should information involving a suspected counterfeit or falsified product be handled when an individual reports a reaction?

Product authenticity should be treated as proof of clinical causality The report should be excluded from pharmacovigilance because the product was not authentic The product source and nature should be documented accurately and the clinical information assessed under the applicable requirements Only the supply-chain issue should be recorded

Question 8 of 10 What is the primary benefit of controlled coding of special situations?

It eliminates the need for narrative case assessment It supports consistent classification and downstream analysis across cases and organisations It allows causality to be inferred from the coded circumstance It ensures every coded situation becomes an ICSR

Question 9 of 10 A patient receives an incorrect dose but reports no clinical consequence. Which interpretation best reflects the article?

The information is irrelevant because no adverse reaction occurred The event must be coded as an adverse reaction caused by the medicine The information may still be relevant to medication-error monitoring, risk minimisation, or other safety processes The case should be treated as an overdose with a confirmed clinical effect

Question 10 of 10 Which statement best distinguishes an overdose from its clinical consequences?

An overdose is itself proof of an adverse reaction The exposure circumstance and any resulting clinical event should be assessed separately An overdose is reportable only when it was intentional A clinical outcome need not be documented if the excessive exposure is clear

Knowledge Assessment: GVP Module VI Special Situations and ICSR Reporting

Cookie Settings